Sally Nijim, the 2024 CDCN and Biomedical Leadership Fellow at the Perelman School of Medicine, has been selected by the American Society of Hematology (ASH) to receive the 2024 Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award as one of 33 residents and medical students nationally and as the representative from PSOM.

The ASH HONORS Award aims to support talented medical students and residents who are interested in hematology but have not yet entered a hematology-related training program. Recipients receive $5,000 to conduct hematology research projects. Each HONORS participant will have an ASH research mentor who will assist and oversee the awardee’s work and progress.

This was the first time an ASH medical student HONORS award was used to conduct research in Castleman’s disease.

The American Society of Hematology (ASH) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. Since 1958, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology.